approved EB-2 (NIW)

Postdoctoral Researcher

Pharmacology · South Korea · 2025-06-13

Processing Time
350 days
Decision Date
2025-06-13
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in pharmacology, specifically focusing on assessing the pharmacokinetic properties of novel medications using in vitro and in vivo models to minimize adverse drug effects and maximize efficacy for conditions such as diabetes, Alzheimer’s, and cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the 90% failure rate of clinical trials and the multi-billion dollar economic burden of adverse drug reactions in the U.S. healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of 13 publications and 163 citations, with papers ranking in the top 1% of the field, demonstrating significant influence in pharmacology.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's contributions to safer drug formulations and more reliable preclinical testing provide significant public health and economic benefits that justify waiving the labor certification.

Why This Petition Was Approved

The petition was approved because the petitioner demonstrated the national importance of her work in reducing healthcare costs and clinical trial failures. Her extensive publication record and high citation impact proved she is well-positioned to advance the field, and the public health benefits of her research outweighed the need for a labor certification.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
New York 169 days 2025-04-09
The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 40 days 2025-03-24
The petitioner proposes to design novel PK/PD models to determine the efficacy and safety of new drugs using clinical data and computational drug modeling. This work focuses on reducing toxicity, optimizing dosage, and increasing the success rate of drug approvals to make therapies safer and more accessible.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 350 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist